Lindsey Baden, MD

Brigham and Women's Hospital

Boston, Massachusetts - 02115 (617-732-6237)

CLINICAL TRIALS 2
CONDITIONS2
INTERVENTIONS4
SINCE2009

A Trial to Evaluate the Safety and Immunogenicity of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adult Volunteers

October 2010 - October 2012

Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults

February 2009 - November 2010

Acquired Immunodeficiency Syndrome

HIV Infections

Placebo Control

Ad35-Env Vaccine

Ad26.Enva.01 Vaccine

Ad5.Enva.48 Hiv-1 Vaccine

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Lindsey Baden, MD

Brigham and Women's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP